Operator LP — 2021 Investments
5 investments dated 2021 · listed companies and verified rows first · show all
Finaloop provides an AI-powered financial platform combining accounting software with oversight from dedicated accountants to deliver real-time accounting, inventory tracking, and finance operations, including reconciled P&L, balance sheet, cash flow, and SKU-level margins.
AI & Machine LearningE-commerceFintech
Yaron Revah(Founder)inEliran Azulai(Founder)Lio Pinchevski(Founder)Lioran Pinchevski(Founder)Omri Haim(Founder)
Co-investorsAccelAlephAxon VenturesCommerce VenturesLightspeed Venture PartnersVesey Ventures+1 more
Human First developed Atlas, a platform providing evidence and insights related to digital health measurement; the company and its Atlas product have been acquired by ICON.
Data & InfrastructureDigital HealthHealthtech
Gregory Whiteside(CEO)
Co-investorsDorm RoomFounder CollectiveLux CapitalPanache VenturesThreshold VenturesArkitekt Ventures+7 more
Iterative Health is a healthcare technology and services company that combines clinical trial expertise with AI to help research teams and study sponsors expand and speed up patients' access to novel therapeutics.
AI & Machine LearningBiotechHealthtechCambridge, US
Jonathan Ng(Executive Officer, Director)inJonathan Ng, MBBS(Founder / CEO)
BoardPeter Moran(Director)Nan Li(Director)inCharles Cooney(Director)
Co-investors515 VenturesAlumni VenturesBreyer CapitalG Vision CapitalGV (Google Ventures)HaloHealth+15 more
Oshi provides virtual gastrointestinal care delivered by gastroenterologists, dietitians, and gut-brain specialists to patients seeking treatment for GI conditions.
Digital HealthHealthtech
Sam Holliday(CEO)in
Co-investorsBessemer Venture PartnersCVS Health VenturesFlare Capital PartnersFrist Cressey VenturesKoch Disruptive TechnologiesOak HC/FT+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Datagen Technologies
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






















